Logo

Burning Rock Biotech: Jing Rong, Licen Xu

Jun 24, 2022

Jing Rong has resigned from the board of directors of Burning Rock Biotech, and Licen Xu has been appointed as a new independent director. Xu has over 15 years of experience in the commercialization of biomedical products. She is the chief commercial officer of FlashDx, a molecular diagnostics point-of-care company, and an independent board member of synthetic DNA firm Ribbon Biolab. Xu also served as VP of strategic product management and lifecycle management at Roche Diagnostics and as VP of strategic marketing and product management at Illumina. She holds a PhD in molecular biology from the University of Zurich and an MS in biophysics from Tsinghua University.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.